TW201206418A - Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease - Google Patents

Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease Download PDF

Info

Publication number
TW201206418A
TW201206418A TW100123320A TW100123320A TW201206418A TW 201206418 A TW201206418 A TW 201206418A TW 100123320 A TW100123320 A TW 100123320A TW 100123320 A TW100123320 A TW 100123320A TW 201206418 A TW201206418 A TW 201206418A
Authority
TW
Taiwan
Prior art keywords
contact lens
panthenol
composition
eye
solution
Prior art date
Application number
TW100123320A
Other languages
English (en)
Chinese (zh)
Inventor
Brien Anthony Holden
Original Assignee
Holden Brien Vision Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010902954A external-priority patent/AU2010902954A0/en
Application filed by Holden Brien Vision Inst filed Critical Holden Brien Vision Inst
Publication of TW201206418A publication Critical patent/TW201206418A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Eyeglasses (AREA)
TW100123320A 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease TW201206418A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU2010902954A AU2010902954A0 (en) 2010-07-02 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Publications (1)

Publication Number Publication Date
TW201206418A true TW201206418A (en) 2012-02-16

Family

ID=45401233

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100123320A TW201206418A (en) 2010-07-02 2011-07-01 Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Country Status (9)

Country Link
US (2) US9161923B2 (enExample)
EP (1) EP2588096A4 (enExample)
JP (1) JP2013534527A (enExample)
CN (1) CN103037858A (enExample)
AU (1) AU2011274245B2 (enExample)
CA (1) CA2803935A1 (enExample)
SG (1) SG186782A1 (enExample)
TW (1) TW201206418A (enExample)
WO (1) WO2012000055A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
US9161923B2 (en) * 2010-07-02 2015-10-20 Brien Holden Vision Institute Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
AR089518A1 (es) * 2012-12-27 2014-08-27 Vega Villavicencio Parsival Costra artificial porosa semipermeable
EP2898888B8 (en) * 2014-01-22 2019-06-12 VISUfarma B.V. Composition comprising iota-carrageenan against viral Conjunctivitis
CA2945604C (en) * 2014-08-08 2022-08-23 Shenzhen Hightide Biopharmaceutical, Ltd. Liquid formulation compositions, medicament delivery devices, and methods of preparation and use thereof
PL3072503T3 (pl) * 2015-03-26 2021-01-11 D.M.G. Italia Srl Kompozycja okulistyczna do ochrony rogówki
EP3496516B1 (en) 2017-12-11 2020-02-19 Ion Beam Applications S.A. Superconductor cyclotron regenerator
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3827818A1 (en) * 2019-11-26 2021-06-02 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1124582T3 (da) * 1998-10-27 2004-03-22 Alcon Mfg Ltd Konserveringssystem til topisk indgivelige farmaceutiske præparater
US20070104744A1 (en) 2000-11-08 2007-05-10 Fxs Ventures, Llc Ophthalmic and contact lens solutions containing forms of vitamin b
IL156766A0 (en) * 2001-01-09 2004-02-08 Louis Johan Wagenaar Procedure and composition of treatment and/or care of the eye
MY128762A (en) * 2001-01-12 2007-02-28 Novartis Ag Lens care product containing dexpanthenol
DE10161110A1 (de) * 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
US20050220742A1 (en) 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US20070243275A1 (en) 2006-04-13 2007-10-18 Gilbard Jeffrey P Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
WO2009094466A2 (en) 2008-01-22 2009-07-30 University Of Florida Research Foundation, Inc. Contact lenses for extended release of bioactive agents containing diffusion attenuators
US20100087550A1 (en) * 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
NL2002214C2 (en) 2008-11-17 2010-05-18 Louis Johan Wagenaar Contact lens care solution.
EP3363425A1 (en) 2009-05-01 2018-08-22 Advanced Vision Research, Inc. Cleanser compositions and methods for using the same
IT1393712B1 (it) 2009-05-13 2012-05-08 Bruschettini Srl Composizioni oftalmiche per la riepitelizzazione, la cicatrizzazione, e la disinfezione dei tessuti oculari
US9161923B2 (en) * 2010-07-02 2015-10-20 Brien Holden Vision Institute Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease

Also Published As

Publication number Publication date
EP2588096A1 (en) 2013-05-08
US20160074345A1 (en) 2016-03-17
WO2012000055A1 (en) 2012-01-05
CN103037858A (zh) 2013-04-10
EP2588096A4 (en) 2013-12-25
CA2803935A1 (en) 2012-01-05
SG186782A1 (en) 2013-02-28
AU2011274245B2 (en) 2014-07-17
US9161923B2 (en) 2015-10-20
US20130102679A1 (en) 2013-04-25
AU2011274245A1 (en) 2013-01-10
JP2013534527A (ja) 2013-09-05

Similar Documents

Publication Publication Date Title
JP7432654B2 (ja) 人工涙液、コンタクトレンズ及び薬剤担体組成物並びにその使用方法
JP7329019B2 (ja) 老視を治療するための組成物及び方法
TW201206418A (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
JP5877885B2 (ja) 防腐剤を含まない非粘性プロスタグランジン系点眼液用のポリマー送達システム
CN102811610B (zh) 无刺激性眼科聚维酮碘组合物
US20090010850A1 (en) Formulations and methods for treating dry eye
TWI650122B (zh) 用於預防及／或治療乾眼症之組成物、方法及／或裝置
CA2764477A1 (en) Ophthalmic formulations, methods of manufacture, and methods of using same
AU2011282683B2 (en) Preservative free brimonidine and timolol solutions
JP2011503061A (ja) 浸透圧活性剤及び血管収縮剤を含む眼けん腫脹の治療及び防止のための組成物
MX2011009802A (es) Formulaciones oftalmicas de cetirizina y metodos de uso.
AU2013256144A1 (en) Ophthalmic compositions with improved dessication protection and retention
JP2018508545A (ja) ブリモニジン及びチモロールの固定用量合剤
CN113227304A (zh) 人工泪液、隐形眼镜和药物载体组合物及其使用方法
EP2379078A2 (en) Topical formulations of flap inhibitors for administration to an eye
JP2010526085A (ja) 抗炎症化合物によるｎ−ハロゲン化アミノ酸処方物
JP2017119669A (ja) 異物感改善用眼科組成物
CN116981457A (zh) 有效预防、控制和根除老花眼的低浓度剂量的协同眼科组合物
JP5957517B2 (ja) 結膜弛緩症治療用の点眼薬
HK1182338A (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
CN116270442A (zh) 一种用于矫正近距离视力的眼用制剂